EIF4B Polyclonal Antibody

EIF4B Polyclonal Antibody

The EIF4B polyclonal antibody is a highly specific and sensitive tool for the detection and quantification of EIF4B protein in various biological samples. This antibody is produced by immunizing rabbits with a synthetic peptide corresponding to the C-terminal region of human EIF4B protein. The resulting polyclonal antibody has been extensively validated for its specificity and sensitivity in Western blotting, immunoprecipitation, and immunofluorescence assays.

The EIF4B protein is a key regulator of translation initiation, which plays a critical role in protein synthesis and cellular growth. Dysregulation of EIF4B expression or function has been implicated in various diseases, including cancer, neurodegenerative disorders, and viral infections. Therefore, the EIF4B polyclonal antibody is a valuable tool for studying the molecular mechanisms underlying these diseases and for developing novel therapeutic strategies.

The EIF4B polyclonal antibody is supplied as a purified IgG fraction, which has been affinity-purified from rabbit serum using protein A chromatography. The antibody is provided in a liquid form, which can be easily diluted and used for various applications. The antibody has been optimized for use in Western blotting, immunoprecipitation, and immunofluorescence assays, and it has been shown to detect endogenous EIF4B protein in various cell lines and tissues.

In summary, the EIF4B polyclonal antibody is a high-quality reagent that provides reliable and reproducible results in the detection and quantification of EIF4B protein. This antibody is suitable for use in a wide range of applications, including basic research, drug discovery, and clinical diagnostics.